Solesence (NASDAQ:SLSN) vs. BioHarvest Sciences (NASDAQ:BHST) Head-To-Head Analysis

BioHarvest Sciences (NASDAQ:BHST) and Solesence (NASDAQ:SLSN) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.

Valuation and Earnings

This table compares BioHarvest Sciences and Solesence”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioHarvest Sciences	$34.51 million	1.22	-$11.14 million	($0.59)	-3.64
Solesence	$62.06 million	1.23	$1.79 million	$0.01	107.67

Solesence has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Solesence, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for BioHarvest Sciences and Solesence, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1	0	1	0	2.00
Solesence	1	0	0	0	1.00

BioHarvest Sciences currently has a consensus price target of $7.50, suggesting a potential upside of 248.84%. Given BioHarvest Sciences’ stronger consensus rating and higher possible upside, analysts clearly believe BioHarvest Sciences is more favorable than Solesence.

Institutional & Insider Ownership

70.2% of Solesence shares are held by institutional investors. 4.8% of Solesence shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares BioHarvest Sciences and Solesence’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-32.54%	-76.03%	-25.30%
Solesence	1.56%	5.39%	1.78%

Volatility and Risk

BioHarvest Sciences has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, Solesence has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.

Summary

Solesence beats BioHarvest Sciences on 11 of the 14 factors compared between the two stocks.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.